Otc - Active Ingredient
Calc fluor 12X; Calc phos 12X; Causticum 7X; Cineraria maritima 6X; Euphrasia 7X; Sepia 7X; Silicea 13X
Cataract
FDA Label NDC 68770-210
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Natural Ophthalmics, Inc for the product Cataract (NDC 68770-210). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding otc - active ingredient, indications & usage, warnings:, otc - pregnancy or breast feeding, otc - keep out of reach of children, inactive ingredient, directions:, other, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Indications & Usage
According to homeopathic indications, these ingredients are intended to stimulate and help the body counteract the symptoms of cataracts.
Warnings:
• For oral use only. If you experience eye pain, changes in vision, continued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours, discontinue use and consult a physician.
Otc - Pregnancy Or Breast Feeding
Pregnant or nursing women should consult their doctor before use.
Otc - Keep Out Of Reach Of Children
Keep out of reach of children
Inactive Ingredient
organic sucrose
Directions:
Dissolve three pellets under tongue three times per day or as directed by a medical professional.
Other
Do not use if tamper evident seal is broken.
*The letters “HPUS” indicate that the components in this product are officially monographed in the Homeopathic Pharmacopoeia of the United States.
† Claims based on traditional homeopathic practice, not accepted medical evidence.
Not FDA evaluated.
Manufactured for: Natural Ophthalmics, Inc. PO Box 1510 Dillon, CO 80435 PH: 877-220-9710
* Please review the disclaimer below.
